Epstein-Barr virus entry utilizing HLA-DP or HLA-DQ as a coreceptor
about
Structure of a trimeric variant of the Epstein-Barr virus glycoprotein BAssembly and architecture of the EBV B cell entry triggering complexCharacteristics of Epstein-Barr virus envelope protein gp42.Epstein-Barr virus gH is essential for penetration of B cells but also plays a role in attachment of virus to epithelial cells.Establishment of latent Epstein-Barr virus infection and stable episomal maintenance in murine B-cell lines.Mapping the N-terminal residues of Epstein-Barr virus gp42 that bind gH/gL by using fluorescence polarization and cell-based fusion assaysMutational analyses of Epstein-Barr virus glycoprotein 42 reveal functional domains not involved in receptor binding but required for membrane fusionFerritin light chain and squamous cell carcinoma antigen 1 are coreceptors for cellular attachment and entry of hepatitis B virus.Human cytomegalovirus virion protein complex required for epithelial and endothelial cell tropismLytic viral replication as a contributor to the detection of Epstein-Barr virus in breast cancerStructure of unliganded HSV gD reveals a mechanism for receptor-mediated activation of virus entry.In vivo function of a gammaherpesvirus virion glycoprotein: influence on B-cell infection and mononucleosis.Epstein-Barr virus-associated lymphomas.Epstein-Barr virus shed in saliva is high in B-cell-tropic glycoprotein gp42.Investigation of the function of the putative self-association site of Epstein-Barr virus (EBV) glycoprotein 42 (gp42).Membrane anchoring of Epstein-Barr virus gp42 inhibits fusion with B cells even with increased flexibility allowed by engineered spacersSoluble Epstein-Barr virus glycoproteins gH, gL, and gp42 form a 1:1:1 stable complex that acts like soluble gp42 in B-cell fusion but not in epithelial cell fusion.Mutational analysis of the HLA class II interaction with Epstein-Barr virus glycoprotein 42.Modulation of cellular signaling by herpesvirus-encoded G protein-coupled receptors.Coreceptor restriction within the HLA-DQ locus for Epstein-Barr virus infectionThe KGD motif of Epstein-Barr virus gH/gL is bifunctional, orchestrating infection of B cells and epithelial cells.Binding-site interactions between Epstein-Barr virus fusion proteins gp42 and gH/gL reveal a peptide that inhibits both epithelial and B-cell membrane fusion.Characterization of EBV gB indicates properties of both class I and class II viral fusion proteins.Human cytomegalovirus uses two distinct pathways to enter retinal pigmented epithelial cells.A soluble form of Epstein-Barr virus gH/gL inhibits EBV-induced membrane fusion and does not function in fusion.The BDLF3 gene product of Epstein-Barr virus, gp150, mediates non-productive binding to heparan sulfate on epithelial cells and only the binding domain of CD21 is required for infection.Analysis of Epstein-Barr virus glycoprotein B functional domains via linker insertion mutagenesisCleavage and secretion of Epstein-Barr virus glycoprotein 42 promote membrane fusion with B lymphocytes.Mechanisms of receptor/coreceptor-mediated entry of enveloped viruses.HLA-DQ β1 alleles associated with Epstein-Barr virus (EBV) infectivity and EBV gp42 binding to cells.Use of gHgL for attachment of Epstein-Barr virus to epithelial cells compromises infection.Murine gammaherpesvirus 68 lacking gp150 shows defective virion release but establishes normal latency in vivo.Nonmuscle myosin heavy chain IIb mediates herpes simplex virus 1 entryHuman monocytic cell lines transformed in vitro by Epstein-Barr virus display a type II latency and LMP-1-dependent proliferation.Epstein-Barr virus promotes interferon-alpha production by plasmacytoid dendritic cellsInhibition of EBV-mediated membrane fusion by anti-gHgL antibodies.Everyone comes from somewhere: systemic lupus erythematosus and Epstein-Barr virus induction of host interferon and humoral anti-Epstein-Barr nuclear antigen 1 immunityInteraction of glycoprotein H of human herpesvirus 6 with the cellular receptor CD46.Alternating host cell tropism shapes the persistence, evolution and coexistence of epstein-barr virus infections in human.Human MHC-II with Shared Epitope Motifs Are Optimal Epstein-Barr Virus Glycoprotein 42 Ligands-Relation to Rheumatoid Arthritis.
P2860
Q24645959-7D27B6A2-FCB8-4638-BB2C-EEB99304F74BQ28542501-33133691-E969-4DE2-85D3-57E215762ECCQ33790326-045C0567-A8E8-4716-AD8B-777A2CC627B8Q33807504-0689AFFE-E8AF-4C15-AD72-991EB9BCF795Q33866311-A2281F84-809A-47D0-9920-A1B93D933ACCQ34120826-7456C41C-56C0-4C32-B2EE-6D8DDC53B39FQ34151639-D5CF6204-3503-4B88-AE55-2704DF91FC1DQ34167802-F4FA6B89-174B-4EE9-9C87-34B3DB3D57FFQ34212879-8EC68A8B-F2A2-4DBF-A8C0-FE76FF75A4C6Q34226611-DC74F4D2-7EB0-48D6-AAAF-E653EE17F2DDQ34324896-46A0D7F6-E540-4B30-AE7C-7FB0FF3EE179Q34348276-CFE8E183-7CAC-446A-9E3B-14A0341A0347Q34651670-A057EE05-479A-4D5D-A004-997E5A52439FQ34717579-94D74EF3-E981-4EEB-A4A9-C8C7A61D8285Q35023947-8C018F2D-71BD-4DAB-BBEA-22E967ED0BEDQ35038210-A542A4FA-F345-44D0-8926-30909F774BB6Q35101434-F18F4968-1235-47A4-8B32-6EF5BFB152FAQ35149283-63786ECF-BC34-4B53-A0FD-1973ABE11DC8Q35158385-6D9D344E-4661-45D9-8E22-0BDF1F543D56Q35202365-F284C05C-2C0F-4A02-8D2B-476BEBEC6431Q35652342-9F8EED3A-44B0-4C83-A046-3761D5789DD9Q35948061-A393A602-EA5E-4706-B602-088F6110E0A5Q36253674-1AA85661-1575-455C-BB53-1A113C53BE23Q36289031-C9C30E9B-92C8-4A97-BE2F-50C8BC92B537Q36532893-4FC2BFCF-44F6-4731-A422-9700DE322973Q36945442-ED21D382-AB5B-49AD-9941-3DF050A5613BQ37033353-4685862B-ECA6-410A-B429-59D6ECCD82CBQ37232892-3785B2E9-C23C-4187-8F6F-BA3CCF2FB93BQ37263225-DA326DD7-0B22-4EAF-97BE-3E8990B5067BQ37646908-2BC3E32B-F84C-41C1-9B6B-4D84DC24DA61Q37730214-7D64B2F3-0B78-4A9D-AB88-EFBC19C779BFQ37730255-72A07593-7A68-4CAB-8487-9285EAFFD5C6Q38937427-39BD02A3-FA14-4409-AE8B-5AADD28A1AB5Q39683879-C2488FFD-85AA-4B2A-8DE6-55B3EF075385Q41063107-F92A8B0E-02CC-4933-A00C-D5152B218654Q41931840-0D2BB08E-313E-487F-ADB2-523BCD66E8D7Q42752096-5BE5EECE-D154-4D67-98E6-94D1156EA1B8Q42802486-2C252CDC-D137-4290-BA66-8227B2D9531DQ45372116-E4632E08-25F7-482F-9199-4E8DBDF6F0D2Q47549698-4D6BFEBA-C263-443D-9546-F5308F09113A
P2860
Epstein-Barr virus entry utilizing HLA-DP or HLA-DQ as a coreceptor
description
2000 nî lūn-bûn
@nan
2000 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մարտին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Epstein-Barr virus entry utilizing HLA-DP or HLA-DQ as a coreceptor
@ast
Epstein-Barr virus entry utilizing HLA-DP or HLA-DQ as a coreceptor
@en
type
label
Epstein-Barr virus entry utilizing HLA-DP or HLA-DQ as a coreceptor
@ast
Epstein-Barr virus entry utilizing HLA-DP or HLA-DQ as a coreceptor
@en
prefLabel
Epstein-Barr virus entry utilizing HLA-DP or HLA-DQ as a coreceptor
@ast
Epstein-Barr virus entry utilizing HLA-DP or HLA-DQ as a coreceptor
@en
P2093
P2860
P1433
P1476
Epstein-Barr virus entry utilizing HLA-DP or HLA-DQ as a coreceptor
@en
P2093
P2860
P304
P356
10.1128/JVI.74.5.2451-2454.2000
P577
2000-03-01T00:00:00Z